Abemaciclib,Trastuzumab,Fulvestrant
eli lilly,roche,Astrazeneca
['abema', 'pyrotinib', 'lumina', 'docetaxel', 'monarche', 'monarcher']
#esmo22 mini oral her2 trials from drs. , xu, kim et al. - monarcher mos 31mo w/ abema+tras+fulvestrant vs 21mo for chemo/tras after 2l. but 95% ci upper limit was 1.05 in all and 1.0 in luminal. -phase 3 pyrotinib + docetaxel/tras showed &gt;2x improvement in pfs. 
Oncologist, researcher, & Associate Professor at Memorial Sloan Kettering. Working on optimizing lifestyle & metabolic health to improve cancer risk & outcomes.